Historically, cancer was treated with surgery. You had to cut it out to get a cure. Over the last several decades that has changed with the introduction of radiation therapy and effective chemotherapy. Today, we enter a new era of targeted therapy which is both less toxic and associated with better outcomes -- but this progress has not been cheap. The cost of treatment and cure keeps increasing, and many plan sponsors are worried about having an affordable benefit that allows them to protect members’ health as well as the company’s bottom line.
Join us on October 10 as we discuss the evolving role of pharmacotherapy in the treatment of cancer:
Hear about the latest advances, including gene and cell therapy
Understand the role of integrated care to achieve the best experience and outcomes for patients
Develop an understanding of what employers should consider to achieve access and affordability for members who have cancer
Steve Miller, MD, Senior Vice President and Chief Medical Officer, Express Scripts
Jennifer Campbell, MPH, Assistant Manager, National Business Group on Health